Circulating hexose-derived metabolites are biomarker candidates for diabetes risk prediction
Christian Schulte(Universität Hamburg), Tanja Zeller(Universität Hamburg), V. Salomaa(Finnish Institute for Health and Welfare), Mark Woodward(UNSW Sydney), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Christa Meisinger(University of Augsburg), Allan Linneberg(Frederiksberg Hospital), Francisco Ojeda(Universidad Complutense de Madrid), Maurizio Ferrario(University of Insubria), Renate B. Schnabel(Universität Hamburg), Giovanni Veronesi(University of Insubria), Stefan Blankenberg(Universität Hamburg), Barbara Thorand(Helmholtz Zentrum München), T Joergensen(Frederiksberg Hospital), Wolfgang Köenig(German Centre for Cardiovascular Research)
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k